City page
Helsinki biotech and pharma directory
Helsinki is a life-science cluster in Finland with 5 verified companies in this directory, spanning Diagnostics, Therapeutics, CDMO. Its anchor companies include Aiforia Technologies, Biohit, Valo Therapeutics, Aplagon. Every profile is hand-reviewed against leadership sources, a verified physical address, and regulatory certifications.
Where does this city read strongest?
Diagnostics (2), Therapeutics (2), and CDMO (1). Most visible records: Aplagon, Valo Therapeutics, and Biohit.
Which standards and public evidence are already visible?
GMP (1). Latest review: 22 March 2026. Review cycle: March 2026.
Why does this city matter?
This page brings visible companies and infrastructure records into one practical view of Helsinki.
By category
Helsinki by category
Jump into a category page filtered to this country only.
Full list
Helsinki biotech and pharma directory
5 city records currently match the active filter.
Current review cycle
Aplagon
HelsinkiFinlandTherapeutics
Helsinki clinical-stage biopharmaceutical company developing APAC therapeutics for thromboinflammatory and vascular-occlusion diseases.
- Lead
- Aki PrihtiCEO
- Scale
- Clinical-stage therapeutics platform
Current review cycle
Valo Therapeutics
HelsinkiFinlandTherapeutics
Helsinki immunotherapy company developing antigen-coated oncolytic viruses and vaccine-vector platforms for cancer and infectious-disease treatment.
- Lead
- Paul HighamCEO
- Scale
- Clinical-stage therapeutics platform
Current review cycle
Biohit
HelsinkiFinlandDiagnostics
Helsinki diagnostics company focused on gastrointestinal testing, cancer-risk screening support, and laboratory products for clinical use and prevention workflows.
- Lead
- Jussi HahtelaCEO
- Scale
- Commercial diagnostics platform
Current review cycle
Aiforia Technologies
HelsinkiFinlandDiagnostics
Helsinki diagnostics company building AI-assisted pathology software and clinical decision-support workflows for digital histopathology and healthcare research.
- Lead
- Jukka TapaninenCEO
- Scale
- Commercial diagnostics-software platform
Current review cycle
Nanoform Finland
HelsinkiFinlandCDMO
Helsinki particle-engineering CDMO using proprietary nanoforming technology to improve drug solubility and move small-molecule programs from development into clinical and commercial supply.
- Lead
- Edward HaeggstromChief Executive Officer
- Scale
- Clinical to Commercial
FAQ
Frequently asked questions
- How many biotech companies are in Helsinki?
- Helsinki hosts 5 verified life-science companies in this directory — spanning Diagnostics, Therapeutics, CDMO. The exact count appears in the page header above and updates with each directory refresh.
- What are the leading biotech companies in Helsinki?
- Helsinki's anchor companies include Aiforia Technologies, Biohit, Valo Therapeutics, Aplagon. Each is hand-reviewed against primary leadership sources, a verified physical address, and regulatory certifications.
Related briefs
Briefs that mention Helsinki
Nordic Biotech Landscape 2026: Denmark, Sweden, Finland, Norway
A practical map of the Nordic biotech and pharma landscape in 2026 — 124 operators across Denmark, Sweden, Finland, and Norway, anchored by Novo Nordisk, Genmab, Lundbeck, AstraZeneca Gothenburg, Bavarian Nordic, Orion, and a dense Medicon Valley + Karolinska cluster layer.
Open briefEuropean Vaccines Landscape 2026: Biodefence, mRNA, Allergen, Infectious Disease
A practical map of the European vaccines sector in 2026 — Bavarian Nordic MVA-BN biodefence, BioNTech and CureVac mRNA, ALK-Abelló allergen immunotherapy, Valneva infectious-disease vaccines, Statens Serum Institut, plus a specialised clinical-stage innovator layer.
Open briefEuropean Cardiometabolic Therapeutics 2026: Diabetes, Heart Failure, Fibrosis, Renal
A practical map of the European cardiometabolic therapeutics sector in 2026 — Novo Nordisk (insulin + GLP-1), Zealand Pharma (peptides), AstraZeneca Gothenburg, plus the heart failure + atrial fibrillation + fibrosis + renal therapeutic clusters.
Open briefNext step
Read the city, then widen the view.
Use country and regional pages for wider context, and the company suggestion form for new candidate records.